Lord, Abbett & Co
KYTH

Lord, Abbett & Co’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Lord, Abbett & Co’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-91,960
Closed -$3.01M – 1049
2014
Q3 		$3.01M Sell
91,960
-46,347
-34% -$1.63M 0.01% 831
2014
Q2 		$5.31M Buy
138,307
+53,597
+63% +$1.87M 0.01% 787
2014
Q1 		$3.37M Sell
84,710
-46,814
-36% -$2.09M 0.01% 854
2013
Q4 		$4.9M Buy
+131,524
New +$5.46M 0.01% 846

Other funds holding KYTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return

Lord, Abbett & Co's KYTH Position: Q4 2014 in Review

Lord, Abbett & Co sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2014, closing a stake of 91,960 shares — an estimated $3.01M sold.

Lord, Abbett & Co first reported a position in KYTH in Q4 2013 and held it in 4 quarters. The position peaked at $5.31M in Q2 2014. 106 funds tracked by Wall St. Rank hold KYTH as of Q4 2014.

  • Lord, Abbett & Co reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2014 after selling out during the quarter.
  • Lord, Abbett & Co sold 91,960 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2014, an estimated $3.01M.
  • Lord, Abbett & Co first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q4 2013 and held it in 4 quarters.
  • Lord, Abbett & Co's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $5.31M in Q2 2014.
  • 106 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2014.

Based on Lord, Abbett & Co's 13F filing for Q4 2014, filed 13 Feb 2015.